A NEW MOVEMENT? MANAGING ACUTE AND CHRONIC ...
In 2018, the. American Academy of Neurology guidelines recommended VMAT2 inhibitors as first-line therapy for the treatment of TD. Many other.
Treatment-resistant OCD - Stanford MedicineAn initial loading dose of 12 mg orally or crushed via a nasogastric tube is recommended, followed by 2 mg every. 2 hours until clinical improvement is seen.11 ... Advances in Tardive Dyskinesia:Management. Discontinuation of the offending drugs and supportive care (which may include intensive care) are first-line in treating serotonin syndrome. Drug-induced movement disorders - NPS MedicineWise22,30 Moderate to severe cases often require benzodiazepines and cyproheptadine for treatment of autonomic instability and agitation.3,18,29 Intravenous fluids ...
Autres Cours:
